Current Gastroenterology Reports

, Volume 8, Issue 1, pp 60–66

Management of recurrent viral hepatitis B and C after liver transplantation


DOI: 10.1007/s11894-006-0065-x

Cite this article as:
Montalbano, M. & Neff, G.W. Curr Gastroenterol Rep (2006) 8: 60. doi:10.1007/s11894-006-0065-x


Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contraindication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment outcomes for HCV and HBV in the period following liver transplant.

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.University of CincinnatiCincinnatiUSA